176 related articles for article (PubMed ID: 25848940)
1. EDB Fibronectin Specific Peptide for Prostate Cancer Targeting.
Han Z; Zhou Z; Shi X; Wang J; Wu X; Sun D; Chen Y; Zhu H; Magi-Galluzzi C; Lu ZR
Bioconjug Chem; 2015 May; 26(5):830-8. PubMed ID: 25848940
[TBL] [Abstract][Full Text] [Related]
2. EDB Fibronectin-Specific SPECT Probe
Ye XX; Zhao YY; Wang Q; Xiao W; Zhao J; Peng YJ; Cao DH; Lin WJ; Si-Tu MY; Li MZ; Zhang X; Zhang WG; Xia YF; Yang X; Feng GK; Zeng MS
ACS Omega; 2017 Jun; 2(6):2459-2468. PubMed ID: 30023665
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.
Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR
Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766
[TBL] [Abstract][Full Text] [Related]
4. Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.
Han Z; Li Y; Roelle S; Zhou Z; Liu Y; Sabatelle R; DeSanto A; Yu X; Zhu H; Magi-Galluzzi C; Lu ZR
Bioconjug Chem; 2017 Apr; 28(4):1031-1040. PubMed ID: 28201871
[TBL] [Abstract][Full Text] [Related]
5. EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer.
Li R; He H; Li X; Zheng X; Li Z; Zhang H; Ye J; Zhang W; Yu C; Feng G; Fan W
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2100-2113. PubMed ID: 36807768
[TBL] [Abstract][Full Text] [Related]
6. EDB-FN Targeted Peptide-Drug Conjugates for Use against Prostate Cancer.
Park SE; Shamloo K; Kristedja TA; Darwish S; Bisoffi M; Parang K; Tiwari RK
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277465
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin.
Vaidya A; Ayat N; Buford M; Wang H; Shankardass A; Zhao Y; Gilmore H; Wang Z; Lu ZR
Theranostics; 2020; 10(24):11127-11143. PubMed ID: 33042274
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of ZD2 Peptide
Han Z; Sergeeva O; Roelle S; Cheng H; Gao S; Li Y; Lee Z; Lu ZR
ACS Omega; 2019 Jan; 4(1):1185-1190. PubMed ID: 30729224
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts.
Qiao P; Ayat NR; Vaidya A; Gao S; Sun W; Chou S; Han Z; Gilmore H; Winter JM; Lu ZR
Front Oncol; 2020; 10():586727. PubMed ID: 33194740
[TBL] [Abstract][Full Text] [Related]
10. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M
J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.
Han Z; Cheng H; Parvani JG; Zhou Z; Lu ZR
Magn Reson Med; 2018 Jun; 79(6):3135-3143. PubMed ID: 29082597
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and assessment of ZD2-(
Gao S; Qin J; Sergeeva O; Sergeev M; Qiao P; Roelle S; Avril N; Lee Z; Li Y; Lu Z
Am J Nucl Med Mol Imaging; 2019; 9(5):216-229. PubMed ID: 31772820
[TBL] [Abstract][Full Text] [Related]
13. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Lu ZR; Laney V; Li Y
Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
[TBL] [Abstract][Full Text] [Related]
14. TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells.
Ventura E; Weller M; Macnair W; Eschbach K; Beisel C; Cordazzo C; Claassen M; Zardi L; Burghardt I
J Cell Sci; 2018 Jan; 131(1):. PubMed ID: 29158223
[TBL] [Abstract][Full Text] [Related]
15. EDB fibronectin and angiogenesis -- a novel mechanistic pathway.
Khan ZA; Chan BM; Uniyal S; Barbin YP; Farhangkhoee H; Chen S; Chakrabarti S
Angiogenesis; 2005; 8(3):183-96. PubMed ID: 16308732
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Assessment of the Effectiveness of Magnetic Resonance Molecular Imaging of Extradomain-B Fibronectin for Detection and Characterization of Oral Cancer.
Hall RC; Ayat NR; Qiao PL; Vaidya AM; Ma D; Aminoshariae A; Stojanov I; Lu ZR
Mol Imaging Biol; 2020 Dec; 22(6):1532-1542. PubMed ID: 32789648
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells.
Vaidya A; Wang H; Qian V; Gilmore H; Lu ZR
Cells; 2020 Aug; 9(8):. PubMed ID: 32756405
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound Molecular Imaging of Bladder Cancer via Extradomain B Fibronectin-Targeted Biosynthetic GVs.
Feng Y; Hao Y; Wang Y; Song W; Zhang S; Ni D; Yan F; Sun L
Int J Nanomedicine; 2023; 18():4871-4884. PubMed ID: 37662687
[TBL] [Abstract][Full Text] [Related]
19. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR
Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis.
Qiao PL; Gargesha M; Liu Y; Laney VEA; Hall RC; Vaidya AM; Gilmore H; Gawelek K; Scott BB; Roy D; Wilson DL; Lu ZR
Magn Reson Imaging; 2022 Feb; 86():37-45. PubMed ID: 34801672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
